| P50 | author | Marcela Preininger | Q57611823 |
| | Dominique Limoli | Q59612913 |
| | Vin Tangpricha | Q37828961 |
| P2093 | author name string | Joanna B Goldberg | |
| | Amit Gaggar | |
| | Rabindra Tirouvanziam | |
| | Ruxana T Sadikot | |
| | Julie Laval | |
| | Brahmchetna Bedi | |
| | Milton R Brown | |
| | Osric A Forrest | |
| | Sarah A Ingersoll | |
| | Frances E Lee | |
| P2860 | cites work | High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis | Q24545304 |
| | Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis | Q78599646 |
| | Lactate in cystic fibrosis sputum | Q85196313 |
| | Animal Models of Cystic Fibrosis Pathology: Phenotypic Parallels and Divergences | Q26747210 |
| | Innate immunity in cystic fibrosis lung disease | Q27003347 |
| | Neutrophil plasticity enables the development of pathological microenvironments: implications for cystic fibrosis airway disease | Q28071357 |
| | Origins of cystic fibrosis lung disease | Q28080451 |
| | Targeting neutrophilic inflammation in severe neutrophilic asthma: can we target the disease-relevant neutrophil phenotype? | Q28085559 |
| | Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia | Q33463373 |
| | A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy | Q34047949 |
| | Clara cell impact in air-side activation of CFTR in small pulmonary airways | Q34067502 |
| | LTB4 is a signal-relay molecule during neutrophil chemotaxis | Q34077159 |
| | Linkage of azurophil granule secretion in neutrophils to chloride ion transport and endosomal transcytosis | Q34119970 |
| | Mature cystic fibrosis airway neutrophils suppress T cell function: evidence for a role of arginase 1 but not programmed death-ligand 1. | Q35613230 |
| | Metabolomic Evaluation of Neutrophilic Airway Inflammation in Cystic Fibrosis | Q35914614 |
| | Quantitative proteomics reveals an altered cystic fibrosis in vitro bronchial epithelial secretome | Q36049479 |
| | X-Box-Binding Protein 1 and Innate Immune Responses of Human Cystic Fibrosis Alveolar Macrophages | Q36516884 |
| | Cystic fibrosis: a mucosal immunodeficiency syndrome. | Q36623329 |
| | Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways | Q36670017 |
| | Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD. | Q37073820 |
| | Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs | Q37153791 |
| | Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively? | Q37676994 |
| | Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis | Q37700674 |
| | Cystic fibrosis genetics: from molecular understanding to clinical application | Q38268916 |
| | Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy | Q38392659 |
| | CFTR Expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis | Q38466689 |
| | Neutrophils in cystic fibrosis | Q38725788 |
| | Unexpected function of the phagocyte NADPH oxidase in supporting hyperglycolysis in stimulated neutrophils: key role of 6-phosphofructo-2-kinase. | Q38734669 |
| | Lysophosphatidylcholine increases neutrophil bactericidal activity by enhancement of azurophil granule-phagosome fusion via glycine.GlyR alpha 2/TRPM2/p38 MAPK signaling | Q39726436 |
| | Metformin induces suppression of NAD(P)H oxidase activity in podocytes. | Q39745297 |
| | Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury | Q39935785 |
| | Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4. | Q41164232 |
| | The mechanisms of action of metformin | Q41353984 |
| | Neutrophils in chronic inflammatory airway diseases: can we target them and how? | Q43147096 |
| | Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis | Q43257270 |
| | Primary inflammation in human cystic fibrosis small airways | Q43639063 |
| | Metabolic adaptation of neutrophils in cystic fibrosis airways involves distinct shifts in nutrient transporter expression. | Q43720358 |
| | Characterisation of the range of neutrophil stimulating mediators in cystic fibrosis sputum. | Q53500785 |
| | Risk Factors for Bronchiectasis in Children with Cystic Fibrosis | Q57392934 |
| P433 | issue | 4 | |
| P921 | main subject | cystic fibrosis | Q178194 |
| P304 | page(s) | 665-675 | |
| P577 | publication date | 2018-05-09 | |
| P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
| P1476 | title | Frontline Science: Pathological conditioning of human neutrophils recruited to the airway milieu in cystic fibrosis | |
| P478 | volume | 104 | |